Cost-Effectiveness Analysis of Bevacizumab Biosimilars Versus Originator Bevacizumab for Metastatic Colorectal Cancer: A Comparative Study Using Real-World Data
Lu, Brandon, Dvorani, Erind, Nguyen, Lena, Beca, Jaclyn M., Mercer, Rebecca E., Adamic, Andrea, Muñoz, Caroline, Chan, Kelvin K.W.
Published in Value in health (09.08.2024)
Published in Value in health (09.08.2024)
Get full text
Journal Article